Chunping Du – Trademark Portfolio

Entity Type: 01

Chunping Du holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RECO and SHENNAV. The owner is based in Jiangxi Province.

No. 159, Xiaqutang Group, Yanqu Village,

Shiqiao Town, Yongxin County, Ji'an City,

Jiangxi Province 343421 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SHENNAV
SHENNAV
Registered 2025
RECO
RECO
Registered 2020

Trademark Classifications

Chunping Du's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Chunping Du have?

Chunping Du has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Chunping Du file in?

Chunping Du files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Chunping Du's most well-known trademarks?

Chunping Du's registered trademark portfolio includes well-known marks such as RECO and SHENNAV. These are among 2 currently registered trademarks in the portfolio.

What is Chunping Du's trademark registration success rate?

Chunping Du has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.